Dietary Assessment Primer

What Dietary Assessment Primer does

The Dietary Assessment Primer is a reference resource hosted within the National Cancer Institute's Epidemiology and Genomics Research Program (epi.grants.cancer.gov), providing guidance for researchers on selecting and using dietary assessment methods in research studies. The resource operates under the National Cancer Institute (NCI), the U.S. government's principal agency for cancer research, established in 1937 as part of the National Institutes of Health within the Department of Health and Human Services.

NCI's core product portfolio spans Cancer.gov, the authoritative U.S. cancer information portal; the SEER Program, providing population-based cancer statistics across 21 geographic areas covering 45.9% of the U.S. population since 1975; the Technology Transfer Center, which licenses NCI-developed therapies such as Velcade, Taxol, Halaven, and Papzimeos to commercial partners; the Cancer Trends Progress Report (published since 2001); and a suite of health communications publications. Underlying technology infrastructure includes Adobe Omniture and Google Analytics for web analytics, Qualtrics for survey feedback, Crazy Egg for usability testing, and the SEER database platform. NCI operates 30 divisions, offices, and centers, administers over $3 billion in annual grant awards, and supports research through the 1-800-4-CANCER hotline and LiveHelp chat service.

NCI is funded entirely through U.S. congressional appropriations and does not operate a commercial revenue model. Cancer information, statistics, and the Dietary Assessment Primer are provided free of charge to the public under NCI's statutory mandate to disseminate cancer research. Distribution channels include cancer.gov (global), the 1-800-4-CANCER hotline (U.S.), LiveHelp chat, GovDelivery email newsletters, social media across major platforms, and the SEER database for research and public health professionals. Customer segments span cancer patients and caregivers, cancer researchers, and public health professionals. NCI has no traditional equity ownership structure and is led by Dr. Anthony Letai as the 18th Director.

Name

Dietary Assessment Primer

Legal name

National Cancer Institute

Website

https://cancer.gov

Company type

Private

Founded year

1937

Operating status

Operating

Short description

The Dietary Assessment Primer is an NCI-hosted reference resource providing researchers with guidance on selecting dietary assessment methods for cancer research studies, operated within the U.S. National Cancer Institute's Epidemiology and Genomics Research Program.

Ownership category

akta.pro rank

Product category

Research Methodology Resources

NAICS

Educational Support Services (61171), Voluntary Health Organizations (813212)

akta.pro primary industry

Exposure Assessment & Dietary Intake Modeling (AFALAOAJ)

akta.pro secondary industry

Nutrition & Diet Education (Meal Planning, Macros, Healthy Cooking) (EDAAAHAA)

Keywords

• Dietary assessment methods
• Nutritional epidemiology research
• Research methodology guidance
• Food frequency questionnaires
• Dietary intake measurement

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Operations

Distribution channels5 records

Marketing channels8 records

Core offering

The Dietary Assessment Primer provides guidance and reference material on selecting and using dietary assessment methods for research studies. Hosted at epi.grants.cancer.gov as part of the National Cancer Institute's Epidemiology and Genomics Research Program, it serves as a publicly accessible informational resource for researchers conducting nutritional epidemiology and dietary research, offering methodological information about dietary assessment tools and approaches.

Product overview

The National Cancer Institute operates a comprehensive portfolio of digital information products and services. The primary Cancer.gov website serves as the nation's trusted source for cancer information, supported by specialized platforms including the Technology Transfer Center for commercialization of discoveries, the SEER cancer statistics database, and the Cancer Trends Progress Report. These products work together to fulfill NCI's mandate to collect, analyze, and disseminate cancer research information to patients, researchers, and the public.

Differentiator

Problem solved

Functional benefit

Brands

• SEER Program: Collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 45.9% of the U.S. population.
• Technology Transfer Center (TTC)
• Cancer Trends Progress Report

Products and services

• Dietary Assessment Primer

Quantifiable outcome

• Comprehensive cancer information covering all cancer types, treatment options, clinical trials, and prevention strategies
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• American Cancer Society (ACS)coreStrategic or Co-development PartnerACS collaborates with NCI on the Annual Report to the Nation, providing estimates of new cancer cases and deaths and insights into the contemporary cancer burden. The partnership combines data from NAACCR, SEER, and National Center for Health Statistics.
• Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development PartnerCDC partners with NCI on the Annual Report to the Nation, contributing invasive cancer incidence and survival data from the National Program of Cancer Registries along with SEER data.
• North American Association of Central Cancer Registries (NAACCR)coreStrategic or Co-development PartnerNAACCR collaborates with NCI on cancer surveillance reporting, providing standardized cancer registry data used in the Annual Report to the Nation and other cancer statistics publications.
• LunitcoreTechnology or IntegrationPartnership between NCI and Lunit, a company developing AI-powered solutions for cancer diagnostics and therapeutics. The collaboration blends artificial intelligence tools with clinical data and research practices to advance personalized cancer treatment.
• Federal Laboratory Consortium (FLC)minorStrategic or Co-development PartnerFLC partners with NCI to produce educational videos showcasing successful technology transfer stories, including the commercialization of Axicabtagene ciloleucel and immunotherapy treatments developed through NCI research.
• ProScript Inc.coreStrategic or Co-development PartnerCollaboration with ProScript Inc. led to the discovery of Velcade for the treatment of multiple myeloma, originated from collaboration with NCI scientists in the Developmental Therapeutics Program.
• Bristol-Myers SquibbcoreStrategic or Co-development PartnerBristol-Myers Squibb partnered with NCI in the 1980s for the full development of the drug Taxol, a major cancer treatment.
• Eisai Inc.coreStrategic or Co-development PartnerTechnology transfer partnership resulting in the development of Halaven (eribulin), a prescription medicine for treating breast cancer that has spread to other parts of the body.
• United TherapeuticscoreStrategic or Co-development PartnerPartnership resulting in FDA approval of Papzimeos, a groundbreaking immunotherapy for adult patients with Recurrent Respiratory Papillomatosis (RRP), the first immunotherapy for this condition.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• USDA FoodData Central: USDA's authoritative nutrient composition database. Comparable as a federally curated reference resource supporting nutrition research and dietary intake analysis, though focused on food composition data rather than assessment methodology.
• World Health Organization Nutrition Department: UN global nutrition authority publishing dietary guidance, assessment frameworks, and policy recommendations. Comparable as an internationally authoritative nutrition reference, but operates at global policy scale rather than methodological depth for researchers.
• Dietary Guidelines for Americans: Federally co-produced nutrition policy resource from USDA and HHS. Shares federal nutrition guidance status and similar authoritative role; differs in focus on population-level dietary recommendations versus research methodology.
• CDC Division of Nutrition, Physical Activity, and Obesity: Federal public-health nutrition program providing surveillance data, guidance, and assessment frameworks. Comparable as a federal nutrition information resource, but oriented to public-health surveillance rather than individual-level dietary assessment methodology.

Regional players

• European Food Safety Authority (EFSA): EU agency providing scientific advice on nutrition, dietary reference values, and exposure assessment. Comparable as a regulator-driven authoritative nutrition/exposure assessment resource serving researchers, but operates in a different geography with distinct regulatory framework.

Direct peers

• Academy of Nutrition and Dietetics: Professional association providing nutrition guidance, evidence-based resources, and practice guidelines for dietitians and researchers. Comparable as a provider of authoritative nutrition methodology references, but operating as a professional membership organization rather than a federal agency.
• National Cancer Institute SEER Program: Sibling program under NCI providing cancer surveillance data; both share NCI's Epidemiology research infrastructure. Closely comparable in operating model (federal research resource) but contrasted by focus on outcomes surveillance versus assessment methodology.
• NIH Office of Dietary Supplements: NIH resource providing evidence-based dietary supplement information for researchers, health professionals, and consumers. Compares as a sibling NIH information resource with similar public-health, educational mission and similar funding/operating model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/thenci
• YouTubeyoutube.com/NCIgov
• Facebookfacebook.com/cancer.gov
• LinkedInlinkedin.com/company/nationalcancerinstitute
• Instagraminstagram.com/nationalcancerinstitute

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dietary Assessment Primer